Tue, April 25, 2017
Mon, April 24, 2017
Fri, April 21, 2017

Matthew Andrews Initiated (TGTX) at Strong Buy and Held Target at $23 on, Apr 25th, 2017

Matthew Andrews of Jefferies, Initiated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $23 on, Apr 25th, 2017.

Matthew has made no other calls on TGTX in the last 4 months.



There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $18 on, Tuesday, March 7th, 2017
  • Jason Wittes of "Aegis Capital" Initiated at Strong Buy and Held Target at $26 on, Wednesday, February 22nd, 2017